Sandimmun neoral, a new oral formulation of cyclosporin a with improved pharmacokinetic characteristics: safety and tolerability in renal transplant patients
Taesch, S.; Niese, D.; Mueller, E.A.
Transplantation Proceedings 26(6): 3147-3149
1994
ISSN/ISBN: 0041-1345 PMID: 7998097 Document Number: 423997
Document emailed within 1 workday
Related Documents
Tsang, W.K.; Ho, Y.W.; Tong, K.L.; Chan, W.H.; Chan, A. 1996: Safety, tolerability, and pharmacokinetics of Sandimmun Neoral: conversion study in stable renal transplant recipients Transplantation Proceedings 28(3): 1330-1332Massari, P.U.; Grosso, S.; de Boccardo, G.; Vásquez, M.C.; Schiavelli, R.O.; Sabbatiello, R.R.; Casadei, D.H.; Rial, M.C.; Jost, L.J.; Túrin, M.D.; Agost Carreño C, A.; Maggiora, E.C.; Gadea, M.M. 1996: A randomized, controlled, double-blind study of the safety and tolerability of Sandimmun Neoral in stable renal transplant patients. Argentine Multicentre Study Group Transplantation Proceedings 28(6): 3365-3367
Min, Z.L.; Zhao, M.; Zhu, Y.H.; Qi, J.; Wang, L.M.; Wang, Y.W. 1996: Experience with clinical use of Sandimmun Neoral in renal transplant patients Transplantation Proceedings 28(3): 1356-1357
Holt, D.W.; Mueller, E.A.; Kovarik, J.M.; van Bree, J.B.; Richard, F.; Kutz, K. 1995: Sandimmun neoral pharmacokinetics: impact of the new oral formulation Transplantation Proceedings 27(1): 1434-1437
Neumayer, H.H.; Färber, L.; Haller, P.; Kohnen, R.; Maibücher, A.; Schuster, A.; Vollmar, J.; Waiser, J. 1994: Conversion from Sandimmun to Sandimmun Neoral in patients with stable renal allografts: results after 1 month Transplantation Proceedings 26(5): 2944-2948
Dotti, G.; Gaspari, F.; Caruso, R.; Perico, N.; Remuzzi, G.; Barbui, T.; Rambaldi, A. 2001: Pharmacokinetic study of the new cyclosporine-A formulation (Neoral) in adult allogeneic bone marrow transplant recipients Haematologica 86(3): 311-315
Grant, D.; Rochon, J.; Levy, G. 1996: Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group Transplantation Proceedings 28(4): 2232-2233
Wakasugi, H.; Yoshimoto, M.; Ono, T.; Muso, E.; Inui, K.-i. 2002: Effect of probucol on the blood concentration of cyclosporin a in patients with nephrotic syndrome: a case study with a microemulsion formulation (Neoral) Nihon Jinzo Gakkai Shi 44(8): 792-797
Färber, L.; Maibücher, A.; Geissler, F.; Gutzler, F.; Wiesinger, F.O.; Winkler, M. 1994: Favourable clinical results of Sandimmun-Neoral in malabsorbing liver and heart transplant recipients Transplantation Proceedings 26(5): 2988-2993
Browne, B.J.; Jordan, S.; Welsh, M.S.; Van Buren, C.; Kahan, B.D. 1994: Diet and cyclosporin A--pharmacokinetic comparison between Neoral and Sandimmune gelatin capsules Transplantation Proceedings 26(5): 2959-2960
Atkison, P.R.; Grant, D.R.; Williams, S.E.; Howard, J.; Wall, W.J.; Stiller, C.R. 1994: Sandimmune Neoral in paediatric liver transplant recipients with malabsorption of cyclosporin a Transplantation Proceedings 26(5): 2953-2954
Babarykin, D.; Amerika, D.; Adamsone, I.; Valinietse, M.; Rosental, R. 1996: Transfer of patients with kidney grafts to Sandimmun Neoral normalizes the calcium level in erythrocyts Transplantation Proceedings 28(6): 3137
Diliz, H.S.; Olivera, M.A.; Kershenobich, D.; Mercado, M.A.; Orozco, H. 1996: Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients Transplantation Proceedings 28(6): 3348-3350
Lipkin, G.W.; Tucker, B.; Giles, M.; Raine, A.E. 1993: Ambulatory blood pressure and left ventricular mass in cyclosporin- and non-cyclosporin-treated renal transplant recipients Journal of Hypertension 11(4): 439-442
Shaikh, A.; Arendorf, T.M. 1991: Cyclosporin-induced gingival overgrowth in renal transplant patients South African Medical Journal 80(1): 61-62
Wilmink, J.M.; Bras, J.; Surachno, S.; van Heyst, J.L.; van der Horst, J.M. 1989: Bone repair in cyclosporin treated renal transplant patients Transplantation Proceedings 21(1 Part 2): 1492-1494
Weissgarten, J.; Ng, C.; Freidman, E.; Cardella, C.J. 1989: B lymphocytes from stable renal transplant patients do not respond to exogenous lymphokines: comparison of azathioprine and cyclosporin treated patients Transplantation Proceedings 21(1 Part 1): 393-394
Lumlertgul, D.; Noppakun, K.; Rojanasthien, N.; Kanchanarattanakorn, K.; Jittikanont, S.; Manoyot, A.; Bunnachak, D.; Ophascharoensuk, V. 2006: Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients Journal of the Medical Association of Thailand 89(Suppl 2): S73-S78
Woodroffe, R. 1976: Formulation studies on slow-release phosphate tablets for high-dosage administration in renal transplant patients Journal of Pharmacy and Pharmacology 28 Suppl: 68p
Winkler, M.; Haller, G.; Oldhafer, K.; Bechstein, W.O.; Kattner, A.; Maibücher, A.; Färber, L.; Ringe, B.; Christians, U.; Neuhaus, P.; Pichlmayr, R. 1996: A new oral formulation of cyclosporine for early oral immunosuppressive therapy in liver transplant recipients Transplantation 62(8): 1063-1068